These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19450809)

  • 1. Comprehensive management of psychogenic dysphonia: a case illustration.
    Sudhir PM; Chandra PS; Shivashankar N; Yamini BK
    J Commun Disord; 2009; 42(5):305-12. PubMed ID: 19450809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychogenic voice disorders and traumatic stress experience: a discussion paper with two case reports.
    Baker J
    J Voice; 2003 Sep; 17(3):308-18. PubMed ID: 14513954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Voice Quality, Anxiety and Depression Symptoms After Speech Therapy.
    Martinez CC; Cassol M
    J Voice; 2015 Jul; 29(4):446-9. PubMed ID: 25737478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysphonia, Perceived Control, and Psychosocial Distress: A Qualitative Study.
    Misono S; Haut C; Meredith L; Frazier PA; Stockness A; Michael DD; Butcher L; Harwood EM
    J Voice; 2019 Sep; 33(5):682-690. PubMed ID: 29759920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Acoustic Voice Quality Index: toward improved treatment outcomes assessment in voice disorders.
    Maryn Y; De Bodt M; Roy N
    J Commun Disord; 2010; 43(3):161-74. PubMed ID: 20080243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of voice therapy in the treatment of dyspnea and dysphonia in a patient with a vagal nerve stimulation device.
    Gillespie AI; Helou LB; Ingle JW; Baldwin M; Rosen CA
    J Voice; 2014 Jan; 28(1):59-61. PubMed ID: 24070591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guideline: hoarseness (dysphonia).
    Schwartz SR; Cohen SM; Dailey SH; Rosenfeld RM; Deutsch ES; Gillespie MB; Granieri E; Hapner ER; Kimball CE; Krouse HJ; McMurray JS; Medina S; O'Brien K; Ouellette DR; Messinger-Rapport BJ; Stachler RJ; Strode S; Thompson DM; Stemple JC; Willging JP; Cowley T; McCoy S; Bernad PG; Patel MM
    Otolaryngol Head Neck Surg; 2009 Sep; 141(3 Suppl 2):S1-S31. PubMed ID: 19729111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying component parts of indirect and direct voice therapy related to different voice disorders.
    Gartner-Schmidt JL; Roth DF; Zullo TG; Rosen CA
    J Voice; 2013 Mar; 27(2):210-6. PubMed ID: 23352061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and opportunities in the management of the aging voice.
    Johns MM; Arviso LC; Ramadan F
    Otolaryngol Head Neck Surg; 2011 Jul; 145(1):1-6. PubMed ID: 21521897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychogenic dysphonia associated to other diseases: a challenge for speech therapy.
    Nemr K; Simões-Zenari M; Marques SF; Cortez JP; Silva AL
    Pro Fono; 2010; 22(3):359-61. PubMed ID: 21103731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of acoustic analysis of the voice to diagnosis and treatment of functional dysphonia].
    Chernobel'skiĭ SI
    Vestn Otorinolaringol; 2009; (5):40-2. PubMed ID: 20037556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported impact of dysphonia in a primary care population: an epidemiological study.
    Cohen SM
    Laryngoscope; 2010 Oct; 120(10):2022-32. PubMed ID: 20830762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaboration and conquest: MTD as viewed by voice teacher (singing voice specialist) and speech-language pathologist.
    Goffi-Fynn JC; Carroll LM
    J Voice; 2013 May; 27(3):391.e9-391.e14. PubMed ID: 23465525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing voice-therapy and vocal-hygiene treatments in dysphonia using a limited multidimensional evaluation protocol.
    Rodríguez-Parra MJ; Adrián JA; Casado JC
    J Commun Disord; 2011; 44(6):615-30. PubMed ID: 21880326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychogenic voice disorders.
    Kosztyła-Hojna B; Moskal D; Łobaczuk-Sitnik A; Kraszewska A; Zdrojkowski M; Biszewska J; Skorupa M
    Otolaryngol Pol; 2018 Jun; 72(4):26-34. PubMed ID: 30190444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of the Comprehensive Vocal Rehabilitation Program for the treatment of behavioral dysphonia.
    Behlau M; Pontes P; Vieira VP; Yamasaki R; Madazio G
    Codas; 2013; 25(5):492-6. PubMed ID: 24408556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial risk factors which may differentiate between women with Functional Voice Disorder, Organic Voice Disorder and a Control group.
    Baker J; Ben-Tovim D; Butcher A; Esterman A; McLaughlin K
    Int J Speech Lang Pathol; 2013 Dec; 15(6):547-63. PubMed ID: 23075157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the impact of voice training on the vocal quality of professional voice users: implications for vocal health and recommendations for further research.
    Hazlett DE; Duffy OM; Moorhead SA
    J Voice; 2011 Mar; 25(2):181-91. PubMed ID: 20137890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boot camp: a novel intensive approach to voice therapy.
    Patel RR; Bless DM; Thibeault SL
    J Voice; 2011 Sep; 25(5):562-9. PubMed ID: 20570107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice related quality of life after botulinum toxin injection for spasmodic dysphonia.
    Gama AC; Menezes LN; Maia AA; Rezende Neto AL; Oliveira JB
    Rev Laryngol Otol Rhinol (Bord); 2010; 131(1):39-44. PubMed ID: 21077414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.